Skip to main content
. Author manuscript; available in PMC: 2018 Nov 28.
Published in final edited form as: J Control Release. 2017 Sep 20;266:129–139. doi: 10.1016/j.jconrel.2017.09.024

Figure 2. Transport of doxorubicin and its nanoparticle formulation in T-MOC.

Figure 2

(A) Synthesis of hyaluronic acid based NP delivery system. (B) Pharmacokinetics scenarios for free Dox and Dox-HANP considering slow and rapid plasma clearance. (C) Time-lapse fluorescence micrograph of free Dox and Dox-HANP on the T-MOC. The fluorescence intensity is proportional to the doxorubicin concentration.